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Abstract We have identified a novel splice variant of chicken
collagen XIV which contains an insert of three amino acids (Val-
Arg-Thr) in the sixth fibronectin type III-like (FNIII) domain.
The codons for these amino acids are inserted into the mRNA by
skipping of a splice donor site and usage of another donor site
9 bp further downstream in the collagen XIV gene. The
percentage of the new splice variant in the total collagen XIV
mRNA varies between 22 and 46% in different embryonic tissues.
After hatching, however, this percentage increases dramatically
and reaches 86% in adult skeletal muscle and 58% in adult
gizzard, indicating developmental regulation of this splicing
event. Computer modeling suggests that the three extra amino
acids cause an increase in the size of a flexible loop connecting
two L-strands in the sixth FNIII domain. This increase might
affect the exact arrangement of the FNIII domain in the collagen
XIV molecule, thereby modulating its interactions with other
matrix molecules.
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1. Introduction
Collagen XIV is a modular protein of the extracellular ma-
trix consisting of two short triple helical segments and three
noncollagenous domains. Together with collagens IX, XII,
XVI and XIX it has been classi¢ed in a subfamily of collagens
termed ¢bril-associated collagens with interrupted triple heli-
ces (FACITs, for review see [1^4]). Collagen XIV is expressed
in most mesenchymal tissues [5^7] where it appears to interact
with other collagens (mainly collagen type VI [8]), glycosami-
noglycans and proteoglycans [8^11] and matrix receptors on
several cell types [12^14].
The non-collagenous domain at the N-terminus of collagen
XIV is extremely large making up nearly 80% of the entire
polypeptide. The sequences of the chicken [15^18] and the
human [19,20] protein illustrate that this domain is composed
of eight ¢bronectin type III (FNIII) repeats related to ¢bro-
nectin, two von Willebrand factor A-like (vWFA) domains
related to von Willebrand factor and one non-collagenous
domain 4 (NC4 domain) related to collagen type IX. At least
two splice variants have so far been detected with the human
and chicken protein which di¡er in the length and sequence of
their C-terminal non-collagenous domain [16,20]. It is possible
that these variations modulate the proposed interaction of
collagen XIV with interstitial collagen ¢bers [1^4].
Here we describe another splice variant of chicken collagen
XIV that di¡ers from the common form by the insertion of
three amino acids in one of its FNIII domains. Since the
expression of this insert is highly regulated during develop-
ment, we believe that it plays a role in the interaction of
collagen XIV with other matrix proteins.
2. Materials and methods
2.1. Genomic DNA cloning
Genomic DNA was isolated from chicken ¢broblasts by proteinase
K digestion and extensive phenol extraction [21]. A fragment of the
type XIV collagen gene was ampli¢ed with AmpliTaq polymerase
(Perkin Elmer) in the presence of 3 mM MgCl2 using V1 Wg of
genomic DNA and a pair of strand speci¢c primers. These primers
corresponded to the published cDNA sequence [16] except for one
mismatch in each primer that was introduced to facilitate subsequent
cloning (upper primer: CAGGAGTCAGAATTCTTGTTATAGAT-
GA, position 2540^2567; lower primer GTATCGGGTACCA-
GAGGCTGA, position 2709^2729). The fragments were ampli¢ed
through 35 cycles of 1P at 95‡C, 2P at 57‡C and 2P at 72‡C and ligated
into the EcoRI/KpnI site of the plasmid pUC19 [22]. The DNA se-
quence of the insert was determined by the dideoxynucleotide chain-
termination method [23] using the enzyme Sequenase 2.0 (USB).
2.2. Analysis of mRNA transcripts
Total RNA was isolated from various embryonic and adult chicken
tissues by the guanidinium isothiocyanate method [24] using the
RNeasy kit of Qiagen. Poly(A) RNA was separated from ribosomal
RNA by chromatography on Oligotex beads (Qiagen). The mRNA
(V1 Wg) was transcribed at 42‡C into cDNA with 40 units of AMV
reverse transcriptase (Boehringer) following the instructions of the
manufacturer. The reaction was primed with the oligonucleotide cor-
responding to position 2709^2729. The single-stranded cDNA was
ampli¢ed by PCR using conditions and primers described above ex-
cept that 35 cycles of 1P at 95‡C, 1P at 57‡C and 1P at 72‡C were
performed. The products were resolved on a 3% MetaPhor agarose gel
(FMC BioProducts). The band of interest was recovered from the gel
with QiaEXII (Qiagen) and cloned into the EcoRI/KpnI site of
pUC19. The presence or absence of the 9-bp insert was determined
by DNA sequencing [23]. At least 36 individual clones from each
tissue sample were sequenced. The results were statistically evaluated
using the M2 test [25].
2.3. Molecular modeling
The three-dimensional structure of the FNIII domain containing or
lacking the alternative insert was modeled with the help of a computer
using the program Swiss-Model Version 1.1 [26]. The tenth FNIII
domain of ¢bronectin (1TTF) was employed as template [27]. Homol-
ogy modeling, superposition and energy minimization were done fol-
lowing the tutorial provided with the program.
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3. Results
3.1. Identi¢cation of an alternatively spliced insert
Previous cloning e¡orts [15,16] had led to the isolation of
19 di¡erent cDNA clones that spanned the entire mRNA of
chicken collagen XIV. When the sequences of all these clones
were analyzed in detail, a curious variation was observed at
position 2673. Compared with the published cDNA sequence,
2 out of 8 clones covering this region possessed an insert of
9 bp (GTAAGAACG). This insert coded for the three amino
acids Val-Arg-Thr and occurred in the sixth FNIII repeat of
collagen XIV.
To investigate the mechanism by which the 9 bp were in-
serted into the mRNA, we isolated the corresponding region
from the chicken type XIV collagen gene. A PCR with ge-
nomic DNA from chicken ¢broblasts utilizing two primers
that annealed upstream and downstream of the 9-bp insert
yielded a genomic fragment of V2000 bp. Sequencing studies
demonstrated that the sixth FNIII repeat was encoded by two
separate exons. At the 5P end, the genomic fragment contained
134 bp of the ¢rst exon which were followed, at position 2673
of the cDNA, by an intron harboring the splice donor site
GTAAGA (Fig. 1). At the 3P end, the genomic fragment pos-
sessed 56 bp of the second exon which were preceded by the
splice acceptor site CCTGACTATCCAG. The intervening se-
quence between the two exons was 1839 bp. The 9-bp insert
was found at the 5P end of this intron. Skipping of the ¢rst
splice donor site at position 2673 and usage of an alternative
splice donor site 9 bp further downstream (GTCTGT) obvi-
ously leads to the extension of the ¢rst exon by 9 bp. The
three amino acids Val-Arg-Thr are therefore incorporated into
collagen XIV by alternative splicing of the RNA.
3.2. Expression of the alternative insert in di¡erent tissues and
at di¡erent developmental stages
To study the occurrence of the 9-bp insert, we analyzed
8 di¡erent tissues from 16-day old chicken embryos by RT-
PCR. From every tissue sample we obtained a fragment of
V200 bp as predicted from the annealing positions of the two
primers used. The yield of this band was dependent on the
relative amount of collagen XIV mRNA present in each sam-
ple. It was relatively high in all muscular tissues, but relatively
low in liver, brain and calvaria (not shown). Since the PCR
fragments with and without alternative insert could not be
separated from each other on a polyacrylamide gel, they
were cloned into the plasmid pUC19. To determine the per-
centage of fragments with alternative insert, at least 36 clones
derived from each tissue were sequenced. These sequencing
studies demonstrated that approximately one third of the
clones possessed the alternative insert of 9 bp (Fig. 2A).
Some di¡erences were noted between the 8 tissues examined,
skin containing a relatively high percentage of clones with
insert (46%), heart and brain containing a relatively low per-
centage (22%). A statistical evaluation using the M2 test
showed that the di¡erence between skin and heart was highly
signi¢cant (P6 0.05). However, the di¡erences between the
other tissues (skeletal muscle, gizzard, liver, sternum, calvaria)
were too small to allow any predictions. To check the statis-
tical signi¢cance in these cases, the sequences of several hun-
dred cDNA clones would have been required.
When the expression of the 9-bp insert was analyzed at ¢ve
developmental stages, striking di¡erences were observed (Fig.
2B). Skeletal muscle from chicken embryos of day 10 and day
16 expressed the longer splice variant only in a small percent-
age of all collagen XIV mRNA molecules (25^27%), whereas
skeletal muscle from adult chickens of 40 days, 2 years and
8 years expressed it at high level (72^86%, P6 0.01). More-
over, the percentage of molecules with insert did not increase
in a linear fashion, but rather jumped from a relatively low
value during embryogenesis to a high value one month after
hatching. An increase in the percentage of the longer splice
variant was also observed in the developing gizzard. However,
the increase was smaller in this case, embryonic gizzard con-
taining 34% of the longer splice variant, adult gizzard 58%
(not shown).
3.3. Computer modeling
Alignment of all FNIII repeats from chicken collagen XIV
revealed a relatively weak conservation of the amino acid
sequences among the individual repeats (not shown). The
length of the modules varied between 88 and 92 residues.
Only the sixth module with the alternative insert was distinctly
longer (94 residues). The alternative motif Val-Arg-Thr was
not found in any of the other repeats.
To see where the three extra amino acids are situated within
the sixth FNIII module, we performed protein modeling stud-
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Fig. 1. Structure of the chicken collagen XIV gene around the region coding for the sixth FNIII domain. Exons are boxed, the translated se-
quence is given by the single letter code. The alternative insert is shaded dark grey. Positions are indicated according to the published cDNA
sequence and its deduced amino acid sequence [16].
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ies using the Swiss-Model computer program [26]. As tem-
plate we chose the tenth FNIII repeat from human ¢bronec-
tin, whose three-dimensional structure has been solved by
nuclear magnetic resonance (structure of a single module
[27]) as well as by X-ray crystallography (structure of a tan-
dem array of four modules [28]). This structure revealed 7 L-
strands termed A, B, C, CP, E, F and G which form two anti-
parallel L-sheets with three and four strands, respectively. The
sixth FNIII repeat of collagen XIV lacking the alternative
insert could be superimposed on the published structure with-
out collisions of the amino acid side chains (Fig. 3). In this
model, the insertion site for the three amino acids (residue
786) was located within L-strand CP. When the three amino
acids Val-Arg-Thr were included in these modeling studies, it
became evident that they cannot form a loop in the center of
this L-strand. Energy minimization suggested that the three
amino acids rather assume the positions of the three preceding
amino acids Glu-Glu-Ala, which in turn are displaced towards
the loop connecting L-strands C and CP. It is therefore likely
that the incorporation of the alternative insert leads to a re-
markable increase in the length of the connecting loop, which
might a¡ect the arrangement of the sixth FNIII repeat in the
context of the whole collagen XIV molecule.
4. Discussion
Alternative splicing is an important mechanism by which
the diversity of proteins, including several proteins of the ex-
tracellular matrix, is dramatically increased. Here we describe
a novel splice variant of collagen XIV, which contains three
extra amino acids in one of its FNIII domains. The codons
for the three amino acids are inserted into the ¢nal transcript
by skipping of a splice donor site and usage of a cryptic donor
site 9 bp further downstream. Inclusion of the alternative in-
sert is developmentally regulated. In skeletal muscle, the per-
centage of transcripts with insert increases from 25% at em-
bryonic stages to 86% at adult stages.
FNIII domains are often encoded by two exons that togeth-
er encode 90 amino acids [29^32]. The sixth FNIII domain of
collagen XIV with the alternative insert is also encoded by
two exons, but it is unusual in that it comprises 94 amino
acids. No such extended FNIII domain occurs at any other
location in collagen XIV, and no similarly extended domain is
found in the related proteins ¢bronectin [29] and collagen XII
[33]. It is therefore likely that the 9 bp for the three amino
acids were speci¢cally gained at some stage during the molec-
ular evolution of collagen XIV.
The occurrence of the extended FNIII domain is not con-
¢ned to the chicken molecule. A similar FNIII domain with
94 amino acids is also found at the corresponding position in
the human molecule (734^827; note that the position is given
incorrectly as 733^827 in [20]). However, the shorter splice
variant has not yet been identi¢ed in man and it remains to
be demonstrated whether human collagen XIV is subject to a
similar alternative splicing event or whether the longer variant
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Fig. 2. Percentage of transcripts with alternative insert in the total
collagen XIV mRNA population. A: Results obtained with eight
di¡erent tissues from 16-day old chicken embryos. B: Results ob-
tained with samples from skeletal muscle of ¢ve di¡erent develop-
mental stages. Each bar represents the percentage calculated from at
least 36 individual sequences.
Fig. 3. Structure of the sixth FNIII domain from chicken collagen
XIV. The domain lacking the alternative insert is shown on the left,
the domain containing the insert on the right. The polypeptide
backbone is drawn by a thick line, L-strands are given by £at ar-
rows. The position of the alternative insert is indicated by the black
region. Note that the insertion of the three amino acids will increase
the size of the loop connecting L-strands C and CP (black arrow).
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is constitutively expressed. There is a potential splice donor
site in the human cDNA sequence (GTCATA, position 1777^
1782 in GenBank/EMBL database entry M64108) that could
be utilized for the creation of a shorter splice variant. How-
ever, the sequence of the three extra amino acids is not con-
served between the human (Ile-Gly-Thr) and the chicken pro-
tein (Val-Arg-Thr).
Since the incorporation of the alternative insert is develop-
mentally regulated and since the length of the insert (although
not its sequence) is conserved between avians and mammals
we believe that it plays a crucial role. What this role might be
is di⁄cult to predict at present as the exact function of colla-
gen XIV is not yet known [1^4,34]. It is conceivable that it is
related to changes in the function of collagen XIV during
development because the percentage of mRNA molecules
with insert increases dramatically after hatching. The insert
might therefore modulate an interaction of collagen XIV
with another matrix molecule once the tissues of the animal,
especially the muscles, are actively used.
It seems unlikely that the alternative insert will directly
interact with another matrix molecule because its sequence
is not well conserved between chicken and human. Computer
modeling rather suggests that the insert induces an increase in
the size of a £exible loop which connects two L-strands in the
FNIII domain. This increase could a¡ect the arrangement of
the neighboring FNIII domains by changing the geometry
with which the modules are connected in the entire polypep-
tide. In this way, the a⁄nity and/or speci¢city of an adjacent
domain for its ligand could be modulated.
In this context it might be of interest to mention a similar
situation observed with ¢bronectin and its cell binding site.
This site has been traced down to the three amino acid se-
quence Arg-Gly-Asp located in the tenth FNIII domain [29].
For a strong and speci¢c interaction with integrins, ¢bronec-
tin depends on a synergistic binding site which has been
mapped to the ninth FNIII domain [35,36]. It has now been
demonstrated that the geometry (i.e. the ‘tilt’ and ‘twist’ an-
gles [32]) with which the ninth and tenth modules ¢t together
determine both the a⁄nity and speci¢city of integrin binding.
The two modules of ¢bronectin are arranged in a way that the
cell binding site and the synergy region of the neighboring
module come su⁄ciently close together to allow an interaction
with a single integrin molecule [28].
These considerations illustrate that it will probably not be
possible to elucidate the function of the alternative insert in
collagen XIV by performing interaction studies with a single
FNIII domain and other matrix molecules. More elaborate
experiments with constructs encompassing a tandem array
of several FNIII repeats might be required to ¢nally identify
a speci¢c role for this alternatively spliced insert.
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